Cita APA

Leibrand, C. R., Price, D. K., & Figg, W. D. (2016). Androgen receptor splice variant 7 (AR-V7) and drug efficacy in castration-resistant prostate cancer: Biomarker for treatment selection exclusion or inclusion? Cancer Biol Ther.

Chicago Style Citation

Leibrand, Crystal R., Douglas K. Price, i William D. Figg. "Androgen Receptor Splice Variant 7 (AR-V7) and Drug Efficacy in Castration-resistant Prostate Cancer: Biomarker for Treatment Selection Exclusion or Inclusion?" Cancer Biol Ther 2016.

Cita MLA

Leibrand, Crystal R., Douglas K. Price, i William D. Figg. "Androgen Receptor Splice Variant 7 (AR-V7) and Drug Efficacy in Castration-resistant Prostate Cancer: Biomarker for Treatment Selection Exclusion or Inclusion?" Cancer Biol Ther 2016.